These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165 [TBL] [Abstract][Full Text] [Related]
5. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458 [TBL] [Abstract][Full Text] [Related]
6. The effect of L-thyroxine replacement therapy on ischemia-modified albümin and malondialdehyde levels in patients with overt and subclinical hypothyroidism. Erem C; Suleyman AK; Civan N; Mentese A; Nuhoglu İ; Uzun A; Coskun H; Deger O Endocr Res; 2016 Nov; 41(4):350-360. PubMed ID: 27111422 [TBL] [Abstract][Full Text] [Related]
7. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Duntas LH; Mantzou E; Koutras DA Thyroid; 2002 Nov; 12(11):1003-7. PubMed ID: 12490078 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. Caraccio N; Ferrannini E; Monzani F J Clin Endocrinol Metab; 2002 Apr; 87(4):1533-8. PubMed ID: 11932277 [TBL] [Abstract][Full Text] [Related]
14. Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine. Brenta G; Berg G; Miksztowicz V; Lopez G; Lucero D; Faingold C; Murakami M; Machima T; Nakajima K; Schreier L Thyroid; 2016 Mar; 26(3):365-72. PubMed ID: 26839156 [TBL] [Abstract][Full Text] [Related]
15. Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement. Akinci B; Comlekci A; Ali Ozcan M; Demir T; Yener S; Demirkan F; Yuksel F; Yesil S Endocr J; 2007 Feb; 54(1):45-52. PubMed ID: 17090955 [TBL] [Abstract][Full Text] [Related]
16. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Jung CH; Sung KC; Shin HS; Rhee EJ; Lee WY; Kim BS; Kang JH; Kim H; Kim SW; Lee MH; Park JR; Kim SW Korean J Intern Med; 2003 Sep; 18(3):146-53. PubMed ID: 14619383 [TBL] [Abstract][Full Text] [Related]
17. Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer. Sigal GA; Tavoni TM; Silva BMO; Kalil Filho R; Brandão LG; Maranhão RC Thyroid; 2019 Jan; 29(1):53-58. PubMed ID: 30412041 [TBL] [Abstract][Full Text] [Related]
18. Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancer. Ozkan C; Akturk M; Altinova AE; Cerit ET; Gulbahar O; Yalcin MM; Cakir N; Balos Toruner F Endocr J; 2015; 62(12):1091-9. PubMed ID: 26490048 [TBL] [Abstract][Full Text] [Related]
19. Plasma FGF21 levels are increased in patients with hypothyroidism independently of lipid profile. Lee Y; Park YJ; Ahn HY; Lim JA; Park KU; Choi SH; Park DJ; Oh BC; Jang HC; Yi KH Endocr J; 2013; 60(8):977-83. PubMed ID: 23759753 [TBL] [Abstract][Full Text] [Related]
20. Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ; Ozden M Endocr Res; 2003 Aug; 29(3):307-16. PubMed ID: 14535632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]